Yingqiu Zhang
No. 467 Zhongshan Road
Dalian, 116000, China
Dalian, 116000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Targeting Oncogenic HER2 Mutations by Neratinib-induced HER2 Ubiquitination and Degradation in Breast Cancer.
Journal: Current cancer drug targets
Published: January 13, 2026
Brusatol enhances ferroptosis susceptibility in nasopharyngeal carcinoma by downregulating Nrf2 expression.
Journal: European journal of pharmacology
Published: October 30, 2025
PAFAH1B3 promotes gastric cancer progression by enhancing E2F8-mediated transcriptional activation of VEGFA expression.
Journal: Biochemical pharmacology
Published: October 28, 2025
Proximity proteomics reveals OTUD6B regulation of stress granule dynamics through coalescence with VCP/p97.
Journal: Cell death & disease
Published: September 20, 2025
Reversible ubiquitination regulates HSF1 phase separation in response to proteotoxic stress.
Journal: Life sciences
Published: September 15, 2025
Periplocin potentiates ferroptotic cell death in non-small cell lung cancer by inducing the degradation of Nrf2.
Journal: Cancer cell international
Published: February 05, 2025
HSP90 inhibition induces oncogenic EGF receptor degradation to suppress cell growth in non-small cell lung cancer.
Journal: European journal of pharmacology
Published: October 09, 2024
Apigenin Sensitizes Melanoma to Chemo/Radiotherapy and Potentiates Immune Killing by Reducing T Cell PD-1 Expression.
Journal: Phytotherapy research : PTR
Published: September 11, 2024
USP39 phase separates into the nucleolus and drives lung adenocarcinoma progression by promoting GLI1 expression.
Journal: Cell communication and signaling : CCS
Published: August 11, 2024
Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma.
Journal: Biology direct
Published: July 28, 2024
Last Updated: 09/26/2026